Overview

Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department

Status:
Not yet recruiting
Trial end date:
2022-08-31
Target enrollment:
0
Participant gender:
All
Summary
This study aims to compare efficacy of Procedural Sedation with Dexmedetomidine as compared to Midazolam in the pediatric Emergency Department. 210 children aged 6 months to 6 years will be included and randomly assigned to receiving oral or rectal midazolam (standard of care) or intranasal dexmedetomidine for procedures at the emergency department where mainly a sedation and no analgesia is sought. The procedure will be videotaped and analysis is blinded to the medication.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Treatments:
Dexmedetomidine
Midazolam
Criteria
Inclusion Criteria:

- Children aged between 6 months and 6 years presenting at the pediatric emergency
department

- Indication for midazolam as sedation

- Signed informed consent

Exclusion Criteria:

- Contraindication for midazolam

- Contraindication for dexmedetomidine

- Contraindication for moderate sedation in general